Medicine
Volume 36, Issue 11 , Pages 616-619 , November 2008

Neurological rehabilitation and management of spasticity

References 

  1. ICF: International classification of functioning, disability and health. Geneva: World Health Organization; 1999;Also available at: http://www.who.int/classifications/icf/site/index.cfm(accessed 30 July 2008)
  2. Wade DT. Measurement in neurological rehabilitation. Oxford: Oxford University Press; 1992;
  3. Wade DT. Goal planning in stroke rehabilitation: evidence. Top Stroke Rehabil. 1999;6:37–42
  4. Knott M, Voss DE. Proprioceptive neuromuscular facilitation: patterns and techniques. New York: Harper & Row; 1956;
  5. Bobath B. Adult hemiplegia: evaluation and treatment. 2nd edn.. London: Heinemann; 1970;
  6. Brunnstrom S. Movement therapy in hemiplegia. New York: Harper and Row; 1970;
  7. Carr JH, Shepherd RB. A motor relearning programme for stroke. London: William Heinemann Medical Books; 1982;
  8. Turner-Stokes L, Ward A. Guidelines for the use of botulinum toxin (BTX) in the management of spasticity in adults. London: Royal College of Physicians; 2002;
  9. Brookshire RH. An introduction to neurogenic communication disorders. 7th edn.. St Louis: Mosby International; 2007;
  10. Manly T, Robertson IH. The rehabilitation of attentional deficits. In:  Halligan P,  Kischka U,  Marshall JC editor. Handbook of clinical neuropsychology. Oxford: Oxford University Press; 2003;
  11. Wilson B. The natural recovery and treatment of learning and memory disorders. In:  Halligan P,  Kischka U,  Marshall JC editor. Handbook of clinical neuropsychology. Oxford: Oxford University Press; 2003;
  12. Stroke Unit Trialists’ Collaboration. Collaborative systematic review of the randomised trial of organised inpatient (stroke unit) care after stroke. BMJ. 1997;314:1151–1159
  13. Kwakkel G, Wagenaar RC, Twisk JWR, et al. Intensity of leg and arm training after primary middle-cerebral-artery stroke: a randomised trial. Lancet. 1999;354:191–196
  14. Montané E, Vallano A, Laporte JR. Oral antispastic drugs in nonprogressive neurologic diseases: a systematic review. Neurology. 2004;63:1357–1363
  15. Simpson DM, Gracies JM, Graham HK, et al. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008;70:1691–1698

PII: S1357-3039(08)00243-0

doi: 10.1016/j.mpmed.2008.08.007

Medicine
Volume 36, Issue 11 , Pages 616-619 , November 2008

Article Tools